ストックスクリーナーアプリを入手
13.44
2.82%
-0.39
前日終値:
$13.83
開ける：
$13.63
24時間の取引高:
1.76M
Relative Volume:
1.18
時価総額：
$1.95B
収益：
$340.81M
当期純損益:
$-419.65M
株価収益率:
-4.7158
EPS:
-2.85
ネットキャッシュフロー:
$-402.10M
1週間 パフォーマンス:
-1.68%
1か月 パフォーマンス:
-3.66%
6か月 パフォーマンス:
-42.32%
1年 パフォーマンス:
-42.39%
1日の値動き範囲:
$13.25
$14.02
1週間の範囲:
$13.25
$14.71
52週間の値動き範囲:
$10.57
$33.33
Denali Therapeutics Inc Stock (DNLI) Company Profile
名前
Denali Therapeutics Inc
セクター
電話
(650) 866-8547
住所
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO
DNLI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DNLI
Denali Therapeutics Inc
|
13.44 | 2.01B | 340.81M | -419.65M | -402.10M | -2.85 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Denali Therapeutics Inc Stock (DNLI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-10 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2025-03-07 | 再開されました | Morgan Stanley | Overweight |
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2025-01-07 | 開始されました | Robert W. Baird | Outperform |
| 2025-01-03 | 開始されました | William Blair | Outperform |
| 2024-12-16 | アップグレード | Stifel | Hold → Buy |
| 2024-10-10 | 再開されました | Raymond James | Mkt Perform |
| 2024-10-07 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2023-12-13 | 開始されました | Citigroup | Buy |
| 2023-11-20 | 再開されました | JP Morgan | Overweight |
| 2023-10-24 | 再開されました | Cantor Fitzgerald | Overweight |
| 2023-09-06 | 開始されました | B. Riley Securities | Buy |
| 2023-01-30 | 開始されました | SVB Securities | Outperform |
| 2022-12-05 | 開始されました | Cowen | Outperform |
| 2022-11-02 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-11-02 | 開始されました | BofA Securities | Buy |
| 2022-06-23 | 開始されました | Berenberg | Buy |
| 2021-12-10 | 再開されました | Raymond James | Mkt Perform |
| 2021-09-21 | 開始されました | Oppenheimer | Outperform |
| 2021-09-01 | 開始されました | SMBC Nikko | Outperform |
| 2021-05-18 | 開始されました | UBS | Buy |
| 2021-02-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2021-02-10 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2020-11-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-16 | ダウングレード | BTIG Research | Buy → Neutral |
| 2020-09-14 | 再開されました | JP Morgan | Overweight |
| 2020-08-20 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-13 | アップグレード | Evercore ISI | In-line → Outperform |
| 2020-02-28 | アップグレード | Wedbush | Neutral → Outperform |
| 2020-02-24 | 開始されました | Jefferies | Buy |
| 2020-02-19 | 開始されました | Stifel | Hold |
| 2020-01-27 | アップグレード | Goldman | Neutral → Buy |
| 2019-09-26 | 開始されました | Wedbush | Neutral |
| 2019-09-13 | 開始されました | Nomura | Buy |
| 2019-08-09 | 開始されました | BTIG Research | Buy |
| 2019-06-26 | 開始されました | H.C. Wainwright | Buy |
| 2018-11-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-11-12 | 開始されました | Janney | Buy |
| 2018-03-12 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2018-01-02 | 開始されました | Evercore ISI | Outperform |
| 2018-01-02 | 開始されました | Goldman | Neutral |
| 2018-01-02 | 開始されました | JP Morgan | Overweight |
| 2018-01-02 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Denali Therapeutics Inc (DNLI) 最新ニュース
Is Denali Therapeutics Inc. stock overvalued or undervaluedAchieve unparalleled market performance - jammulinksnews.com
Does Denali Therapeutics Inc. stock perform well during market downturnsMaximize gains with expert trading strategies - jammulinksnews.com
What makes Denali Therapeutics Inc. stock price move sharplyCapitalize on market momentum for maximum gains - jammulinksnews.com
How volatile is Denali Therapeutics Inc. stock compared to the marketFree Daily Trading Room Entry - jammulinksnews.com
What is Denali Therapeutics Inc. company’s growth strategyBuild wealth steadily with proven investment strategies - jammulinksnews.com
What is the risk reward ratio of investing in Denali Therapeutics Inc. stockSky-high return potential - jammulinksnews.com
Is Denali Therapeutics Inc. a growth stock or a value stockAccelerated financial growth - jammulinksnews.com
What are analysts’ price targets for Denali Therapeutics Inc. in the next 12 monthsInvest smarter with cutting-edge analytics - jammulinksnews.com
What institutional investors are buying Denali Therapeutics Inc. stockCapitalize on emerging growth stocks - jammulinksnews.com
Is it the right time to buy Denali Therapeutics Inc. stockTransform your portfolio with high-yield stocks - jammulinksnews.com
DNLI's Hunter Syndrome Drug Gets Breakthrough Therapy Designation - MSN
Denali Therapeutics Inc. (DNLI) Secures FDA Priority Review for First-Ever Brain-Penetrant Hunter Syndrome Therapy - Insider Monkey
Price momentum metrics for Denali Therapeutics Inc. explainedStock Portfolio Allocation Guidance for Volatile Markets - metal.it
11 Best Future Stocks to Buy Now - Insider Monkey
Biogen’s BIIB122 Study: A New Hope for LRRK2-Associated Parkinson’s Disease - TipRanks
Can Denali Therapeutics Inc. Rally Enough to Break EvenReal Profit Trade Plan Suggestions Shared Widely - metal.it
Volume Surge May Signal Institutional Interest in Denali Therapeutics Inc.Trade Setups With Clear Risk Limits Highlighted - metal.it
What are the technical indicators suggesting about Denali Therapeutics Inc.Real Time Guidance For 2025 - jammulinksnews.com
How does Denali Therapeutics Inc. generate profit in a changing economyUnlock powerful stock screening tools today - jammulinksnews.com
Published on: 2025-07-28 03:16:35 - jammulinksnews.com
How strong is Denali Therapeutics Inc. company’s balance sheetCapitalize on market momentum for maximum profit - jammulinksnews.com
Published on: 2025-07-27 16:21:55 - jammulinksnews.com
BTIG Reiterates a Buy Rating on Denali Therapeutics (DNLI) With a $32 Price Target - MSN
What drives Denali Therapeutics Inc. stock priceRapid growth opportunities - PrintWeekIndia
Why Denali Therapeutics Inc. stock is on top investor watchlistsStrongest growth potential - jammulinksnews.com
Will Denali Therapeutics Inc. stock benefit from interest rate changesFree Investment Community - jammulinksnews.com
What analysts say about Denali Therapeutics Inc. stockOutstanding capital growth - Autocar Professional
Is Denali Therapeutics Inc. a good long term investmentOutperformance with explosive growth - jammulinksnews.com
Denali Therapeutics Inc. Stock Analysis and ForecastRapidly expanding wealth - jammulinksnews.com
Denali Therapeutics Inc (DNLI) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
0.15%
大文字化:
|
ボリューム (24 時間):